Symcel
PrivateLast Round
Grant
Jun 23, 2026
Total Funding Raised
$4.47M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Symcel is a biotechnology company that develops and markets biocalorimetry-based analytical instrumentation for cell and microbial research, including rapid sterility testing and metabolic monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Symcel Comparables
Compare Symcel with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ridgeview Instruments AB | 79% | |
| Lonza Group | 76% | |
| Rapid Micro Biosystems | 71% |
Symcel Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 23, 2026 | ||||
| Grant | Oct 22, 2025 | ||||
| VC Round | May 28, 2025 | ||||
| VC Round | Mar 14, 2024 | ||||
| VC Round | May 11, 2022 | ||||
Grant | Nov 21, 2017 |
Key People
Founding team and executive leadership
Symcel Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| Flerie Invest | VC Round |
| Flerie AB | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 88% MoM, reaching 1.6K.
- Jun 23, 2026
Received grant funding from CEPI.
Symcel Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Symcel's valuation, stock price, and market status.
Is Symcel a public or private company?
Symcel is a private company.
What is the current stock price of Symcel?
Symcel is a private company with no public stock price. No recent secondary market data is available.
How much is Symcel worth (valuation)?
Valuation information for Symcel is not publicly available.
Can I buy Symcel stock?
Symcel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Symcel's last funding round?
Symcel's most recent funding round was Grant on June 23, 2026.
Who are the main investors in Symcel?
Key investors in Symcel include CEPI.
Will Symcel IPO soon?
No public IPO plans have been announced for Symcel.
How can I track Symcel secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Symcel's secondary market activity and sign up for updates.